Back
Liberty Formula One Group Vs. NovoCure Industry Stock Comparison
Sell
48
FWONK
Liberty Formula One Group
Last Price:
70.53
Seasonality Move:
7.78%
Sell
47
NVCR
NovoCure
Last Price:
14.77
Seasonality Move:
6.82%
Sell
48
Liberty Formula One Group (FWONK)
is a Sell
Is Liberty Formula One Group a Buy, Sell or Hold?
- The current Liberty Formula One Group [FWONK] share price is $70.55. The Score for FWONK is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- FWONK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
47
NovoCure (NVCR)
is a Sell
Is NovoCure a Buy, Sell or Hold?
- The current NovoCure [NVCR] share price is $14.78. The Score for NVCR is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- NVCR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
FWONK Stock Price Chart
What is Liberty Formula One Group's stock price today?
-
The Liberty Formula One Group share price today is $70.55
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FWONK is experiencing selling pressure, which indicates risk of future bearish movement.
NVCR Stock Price Chart
FWONK Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.66 | Buy |
| Relative Strength Index (14 RSI): | 61.26 | Buy |
| Chaikin Money Flow: | -692365 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (67.03 - 69.75) | Buy |
| Bollinger Bands (100): | (64.11 - 69.81) | Buy |
NVCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.18 | Sell |
| Relative Strength Index (14 RSI): | 61.74 | Buy |
| Chaikin Money Flow: | -175369 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (12.21 - 14.43) | Buy |
| Bollinger Bands (100): | (12.95 - 15.47) | Buy |
FWONK Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 69.89 | Buy |
| 20-day SMA: | 68.76 | Buy |
| 50-day SMA: | 68.93 | Buy |
| 200-day SMA: | 66.98 | Buy |
| 8-day EMA: | 69.96 | Buy |
| 20-day EMA: | 69.13 | Buy |
| 50-day EMA: | 68.41 | Buy |
| 200-day EMA: | 67.54 | Buy |
NVCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.99 | Buy |
| 20-day SMA: | 13.03 | Buy |
| 50-day SMA: | 14.19 | Buy |
| 200-day SMA: | 17.01 | Sell |
| 8-day EMA: | 13.31 | Buy |
| 20-day EMA: | 13.21 | Buy |
| 50-day EMA: | 13.76 | Buy |
| 200-day EMA: | 22.18 | Sell |
Liberty Formula One Group Earnings Growth & FWONK Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $0.12 per share, an increase this year of $0.25 per share, and an increase next year of $0.34 per share.
NovoCure Earnings Growth & NVCR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.44 per share, and a decrease next year of $0.20 per share.
Liberty Formula One Group Technical Analysis
| Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NovoCure Technical Analysis
| Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||